Clinical Trial

Studio TIARA: Alessitimia ed Emicrania Cronica

Study acronym: TIARA
Enrolling by Invitation
View on ClinicalTrials.gov →
Record status
This record was last updated October 2, 2025 (before its estimated December 2025 completion). Its status may not reflect the trial's current state.
Summary
The aim of this observational, cross-sectional study is to investigate the relationship between alexithymia and migraine frequency (considering alexithymia a condition that can influence the severity of the clinical phenotype of migraine, favoring its chronicization), in an analysis adjusted for psychiatric comorbidity (for anxiety and depression, potentially influencing migraine chronicization) and for personalogical factor represented by apathy.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-03-21.
Trial Details
NCT Number NCT06891053
Lead Sponsor Azienda Sanitaria Locale di Alessandria
Conditions Migraine, Alexithymia
Enrollment 350 participants
Start Date 2022-05-30
Primary Completion 2025-12 (estimated)
Study Completion 2025-12-31 (estimated)
Updated on ClinicalTrials.gov 2025-10-02